Veeva Systems Inc Class A (VEEV)vsZhongchao Inc (ZCMD)
VEEV
Veeva Systems Inc Class A
$178.11
-0.56%
HEALTHCARE · Cap: $29.44B
ZCMD
Zhongchao Inc
$1.80
-0.55%
HEALTHCARE · Cap: $6.96M
Smart Verdict
WallStSmart Research — data-driven comparison
Veeva Systems Inc Class A generates 24259% more annual revenue ($3.20B vs $13.12M). VEEV leads profitability with a 28.4% profit margin vs -13.0%. VEEV earns a higher WallStSmart Score of 69/100 (B-).
VEEV
Strong Buy69
out of 100
Grade: B-
ZCMD
Avoid29
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+25.9%
Fair Value
$238.92
Current Price
$178.11
$60.81 discount
Intrinsic value data unavailable for ZCMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 29.4%
16.0% revenue growth
Earnings expanding 23.2% YoY
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
ROE of -5.9% — below average capital efficiency
Revenue declined 32.9%
Earnings declined 91.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : VEEV
The strongest argument for VEEV centers on Debt/Equity, Profit Margin, PEG Ratio. Profitability is solid with margins at 28.4% and operating margin at 29.4%. Revenue growth of 16.0% demonstrates continued momentum.
Bull Case : ZCMD
The strongest argument for ZCMD centers on Price/Book, Debt/Equity, Altman Z-Score.
Bear Case : VEEV
The primary concerns for VEEV are P/E Ratio.
Bear Case : ZCMD
The primary concerns for ZCMD are Market Cap, Return on Equity, Revenue Growth.
Key Dynamics to Monitor
VEEV profiles as a growth stock while ZCMD is a turnaround play — different risk/reward profiles.
VEEV carries more volatility with a beta of 1.12 — expect wider price swings.
VEEV is growing revenue faster at 16.0% — sustainability is the question.
VEEV generates stronger free cash flow (100M), providing more financial flexibility.
Bottom Line
VEEV scores higher overall (69/100 vs 29/100), backed by strong 28.4% margins and 16.0% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Veeva Systems Inc Class A
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.
Visit Website →Zhongchao Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · China
Zhongchao Inc. provides health care information, education and training services in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?